Walgreens (WAG) Sept Comps Fall More Than Expected at Down 11.1%
Tweet
Share
E-mail
Walgreens (NYSE: WAG) (Nasdaq: WAG) had September sales of $5.48 billion, a decrease of 7.8 percent from last year.
Total front-end sales decreased 0.4 percent compared with the same month in fiscal 2012, while comparable store front-end sales decreased 1.5 percent. Customer traffic in comparable stores decreased 2.3 percent while basket size increased 0.8 percent.
Prescriptions filled at comparable stores decreased by 10.3 percent in September and by a day-fall adjusted (DFA) 6.8 percent.
September pharmacy sales decreased 12.3 percent, while comparable store pharmacy sales decreased 16.1 percent.
Sales in comparable stores decreased by 11.1 percent in September, versus the consensus of 7.5%.
Total front-end sales decreased 0.4 percent compared with the same month in fiscal 2012, while comparable store front-end sales decreased 1.5 percent. Customer traffic in comparable stores decreased 2.3 percent while basket size increased 0.8 percent.
Prescriptions filled at comparable stores decreased by 10.3 percent in September and by a day-fall adjusted (DFA) 6.8 percent.
September pharmacy sales decreased 12.3 percent, while comparable store pharmacy sales decreased 16.1 percent.
Sales in comparable stores decreased by 11.1 percent in September, versus the consensus of 7.5%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yum! Brands adds former HanesBrands CEO to its board
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
- UBS: 'We expect SpaceX shares to continue to trade on demand for tokens'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
